November 08, 2022
Back Page
42
11
A shift in mindset to the experiment itself could lead the way.
November 08, 2022
Features
42
11
Why enabling a shared culture of quality across an organization is key to maintaining pharma’s recent pace of innovation wins—while inspiring new levels of confidence.
November 08, 2022
Executive Roundtable
42
11
Senior leaders focused on the advancement of digital medicine and health meet to discuss the importance of these tools for life sciences companies, payers, and others in harnessing a healthcare future that will be increasingly dominated by holistic treatment and delivery.
November 08, 2022
Executive Profile
42
11
Christi Shaw, CEO of Kite, is working hard to bring cell therapy to the masses, fueled by her family’s personal experiences with cancer.
November 08, 2022
Finance
42
11
Focus is on cash: who’s got it, who doesn’t, and what will it mean?
November 08, 2022
ESG
42
11
The validity of ESG-driven investment and reporting in healthcare.
November 08, 2022
Technology
42
11
AI drives new signal-detection efforts in Alzheimer’s and ALS.
November 08, 2022
Europe Report
42
11
Making sense of surprise rejection of draft proposals.
November 08, 2022
From the Editor
42
11
Executives share insights at recent conferences.
November 08, 2022
Issue PDF
42
11
Click the title above for a link to open the Pharmaceutical Executive November 2022 issue in an interactive PDF format.
October 06, 2022
Washington Report
42
11
The ‘skinny’ user fee reauthorization tables multiple high-profile proposals.